It is a pharma private limited company based in New Delhi, Delhi, India, established in 2011.
2011 | New Delhi, Delhi, India | Struck OffRexter Lifesciences Private Limited, a struck off private limited company, was established on 09 May 2011 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232DL2011PTC218808. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Nikhil Arora (Director), Davender Kumar (Director). Past directors included Nirmal Singh Bhatia, Dharminder Bhatia Singh. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at Wz-106/6, Rajouri Garden Extension, New Delhi, Delhi, 110027.
U24232DL2011PTC218808
218808
09 May 2011
₹2.00 M
₹0.10 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Rexter Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Arora | Director | 31 Jul 2018 | Current |
| Davender Kumar | Director | 31 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jul 2018 | Past |
| Pramod Abcsdd | Director | 31 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rexter Lifesciences Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 10.44% increase in profit. The company's net worth observed a substantial decline by a decrease of 37.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Rexter Lifesciences had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rexter Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rexter Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexter Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rexter Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was completed.
Nikhil Arora was appointed as a Director was appointed as a Director on 31 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Progress on Davender Kumar was appointed as a Director was appointed as a Director on 31 Jul 2018 & has been associated with this company since 7 years 4 months . was documented.
Progress on Rexter Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi. was documented.
Rexter Lifesciences Private Limited was registered on 09 May 2011 with Roc Delhi & aged 14 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Rexter Lifesciences Private Limited is U24232DL2011PTC218808.
Rexter Lifesciences Private Limited is headquartered at Wz-106/6, Rajouri Garden Extension, New Delhi, Delhi, 110027.
Rexter Lifesciences Private Limited was incorporated on 09 May 2011.
The current directors of Rexter Lifesciences Private Limited are
The primary industry of Rexter Lifesciences Private Limited is Pharma.
Rexter Lifesciences Private Limited is unlisted.
The authorized capital of Rexter Lifesciences Private Limited is ₹2.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rexter Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX